Sio Capital Management, LLC Aravive, Inc. Transaction History

Sio Capital Management, LLC

  • $189 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 16, 2020
SELL
$4.7 - $12.06 $321,353 - $824,578
-68,373 Closed
0 $0
Q2 2020

Aug 14, 2020
SELL
$5.18 - $14.81 $42,170 - $120,568
-8,141 Reduced 10.64%
68,373 $796,000
Q1 2020

May 15, 2020
SELL
$3.5 - $13.77 $75,904 - $298,629
-21,687 Reduced 22.08%
76,514 $441,000
Q4 2019

Feb 14, 2020
BUY
$6.21 - $14.02 $609,828 - $1.38 Million
98,201 New
98,201 $1.34 Million

Others Institutions Holding ARAV

# of Institutions
2
Shares Held
28.1K
Call Options Held
0
Put Options Held
0
View Full List

About Aravive, Inc.

ARAV Quotes by TradingView
  • Ticker ARAV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 30,518,300
  • Description
  • Aravive, Inc., a clinical-stage biopharmaceutical company, develops treatments for life-threatening diseases, including cancer and fibrosis in the United States. Its lead product candidate is batiraxcept, an ultrahigh-affinity, decoy protein that targets the GAS6-AXL signaling pathway, which is in Phase III clinical trial for the treatment of pl...
More about ARAV
Track This Portfolio

Track Sio Capital Management, LLC Portfolio

Follow Sio Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sio Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sio Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email